107
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Intranasal Ciclesonide Coadministration with Inhaled Fluticasone Propionate-Salmeterol does not Suppress Cortisol in Allergic Rhinitis Patients

, M.D., , D.O., , B.A., , Ph.D. & , M.D.
Pages 515-520 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Soad A. Mohamad, Mohamed A. Safwat, Mahmoud Elrehany, Sherif A. Maher, Ahmed M. Badawi & Heba F. Mansour. (2021) A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. Drug Delivery 28:1, pages 229-239.
Read now
Robert L Jacobs. (2011) Ciclesonide for the treatment of seasonal allergic rhinitis. Expert Review of Clinical Immunology 7:6, pages 735-741.
Read now
Ben Williams, William B Smith & Frank E Kette. (2008) Intranasal ciclesonide for allergic rhinitis. Journal of Asthma and Allergy 1, pages 49-54.
Read now

Articles from other publishers (4)

Angela M. Donaldson, Garret Choby, Daniel H. Kim, Lisa A. Marks & Devyani Lal. (2020) Intranasal Corticosteroid Therapy: Systematic Review and Meta‐analysis of Reported Safety and Adverse Effects in Children. Otolaryngology–Head and Neck Surgery 163:6, pages 1087-1096.
Crossref
Michael S. Blaiss. (2013) Over-the-counter intranasal corticosteroids: why the time is now. Annals of Allergy, Asthma & Immunology 111:5, pages 316-318.
Crossref
Paul Ratner, Mark A. Wingertzahn, Rolf Herzog, Holly Huang, Shailesh Y. Desai, Gary Maier & Ruediger Nave. (2011) An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis. Pulmonary Pharmacology & Therapeutics 24:4, pages 426-433.
Crossref
Sohita Dhillon & Antona J Wagstaff. (2008) Ciclesonide Nasal Spray. Drugs 68:6, pages 875-883.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.